Historical Volume

PANACEA BIOTEC LTD.

NSE : PANACEABIOBSE : 531349ISIN CODE : INE922B01023Industry : Pharmaceuticals & DrugsHouse : Soshil Kumar Jain
BSE353.80-6.6 (-1.83 %)
PREV CLOSE ( ) 360.40
OPEN PRICE ( ) 366.35
BID PRICE (QTY) 353.90 (120)
OFFER PRICE (QTY) 355.10 (54)
VOLUME 2407
TODAY'S LOW / HIGH ( )352.00 367.50
52 WK LOW / HIGH ( )293.1 647.5
NSE354.40-7.1 (-1.96 %)
PREV CLOSE( ) 361.50
OPEN PRICE ( ) 360.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 354.40 (65)
VOLUME 47098
TODAY'S LOW / HIGH( ) 352.00 367.90
52 WK LOW / HIGH ( )292.4 647
Exchange
Period From  
Period To  
Date Open Price () High Price () Low Price () Close Price () Volume (000's) Turnover ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.